1. Home
  2. SDGR vs NVTS Comparison

SDGR vs NVTS Comparison

Compare SDGR & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • NVTS
  • Stock Information
  • Founded
  • SDGR 1990
  • NVTS 2014
  • Country
  • SDGR United States
  • NVTS United States
  • Employees
  • SDGR N/A
  • NVTS N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • NVTS Semiconductors
  • Sector
  • SDGR Health Care
  • NVTS Technology
  • Exchange
  • SDGR Nasdaq
  • NVTS Nasdaq
  • Market Cap
  • SDGR 1.4B
  • NVTS 1.3B
  • IPO Year
  • SDGR 2020
  • NVTS N/A
  • Fundamental
  • Price
  • SDGR $20.72
  • NVTS $7.80
  • Analyst Decision
  • SDGR Buy
  • NVTS Buy
  • Analyst Count
  • SDGR 8
  • NVTS 7
  • Target Price
  • SDGR $26.75
  • NVTS $4.93
  • AVG Volume (30 Days)
  • SDGR 1.1M
  • NVTS 35.5M
  • Earning Date
  • SDGR 11-11-2025
  • NVTS 11-03-2025
  • Dividend Yield
  • SDGR N/A
  • NVTS N/A
  • EPS Growth
  • SDGR N/A
  • NVTS N/A
  • EPS
  • SDGR N/A
  • NVTS N/A
  • Revenue
  • SDGR $237,917,000.00
  • NVTS $68,167,000.00
  • Revenue This Year
  • SDGR $22.73
  • NVTS N/A
  • Revenue Next Year
  • SDGR $19.85
  • NVTS $8.28
  • P/E Ratio
  • SDGR N/A
  • NVTS N/A
  • Revenue Growth
  • SDGR 18.59
  • NVTS N/A
  • 52 Week Low
  • SDGR $16.60
  • NVTS $1.52
  • 52 Week High
  • SDGR $28.47
  • NVTS $9.48
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 55.56
  • NVTS 59.57
  • Support Level
  • SDGR $20.04
  • NVTS $7.50
  • Resistance Level
  • SDGR $22.03
  • NVTS $8.74
  • Average True Range (ATR)
  • SDGR 0.97
  • NVTS 0.62
  • MACD
  • SDGR 0.12
  • NVTS 0.10
  • Stochastic Oscillator
  • SDGR 62.01
  • NVTS 63.01

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

Share on Social Networks: